Side Effects of Lyrica (Pregabalin)
Lyrica (pregabalin) commonly causes dizziness, somnolence, peripheral edema, weight gain, blurred vision, dry mouth, and cognitive dysfunction as its most frequent side effects. 1
Common Side Effects
Pregabalin's FDA label identifies several common adverse effects that occur in a significant percentage of patients:
Neurological effects:
- Dizziness (up to 38%)
- Somnolence/drowsiness (up to 28%)
- Ataxia (up to 20%)
- Confusion (up to 7%)
- Incoordination (up to 6%)
- Thinking abnormalities (up to 9%)
- Tremor (up to 11%)
Visual disturbances:
- Blurred vision (up to 12%)
- Diplopia/double vision (up to 12%)
- Abnormal vision (up to 5%)
Metabolic effects:
- Weight gain (up to 16%)
- Peripheral edema (up to 9%)
- Increased appetite (up to 6%)
Gastrointestinal effects:
- Dry mouth (up to 6%)
- Constipation (up to 7%)
Serious Side Effects
While less common, pregabalin can cause several serious adverse effects that require monitoring:
Allergic reactions: Potentially life-threatening allergic reactions including swelling of the face, mouth, lips, gums, tongue, throat or neck, rash, hives, and breathing difficulties 1
Suicidal thoughts or actions: Like other antiepileptic drugs, pregabalin may increase the risk of suicidal thoughts or behavior in approximately 1 in 500 people 1
Serious breathing problems: Especially when combined with opioid medications or in patients with pre-existing respiratory conditions 1
Muscle problems: Including muscle pain, soreness, or weakness, particularly when accompanied by fever 1
Visual field defects: Cases of visual field restriction have been reported in clinical trials 2
Special Populations and Considerations
Elderly Patients
Older adults may be more sensitive to side effects, particularly:
Patients with Renal Impairment
- Pregabalin is eliminated primarily through renal excretion
- Dose adjustment is required for patients with creatinine clearance below 60 ml/min 2
- Failure to adjust dosing in renal impairment can lead to increased side effects
Drug Interactions
CNS depressants: Increased risk of sedation, dizziness, and respiratory depression when combined with:
- Opioid pain medications
- Benzodiazepines
- Alcohol
- Other sedating medications 1
ACE inhibitors: Potential for increased risk of angioedema 1
Thiazolidinediones (Avandia, Actos): May increase risk of peripheral edema and weight gain 1
Withdrawal Considerations
Abrupt discontinuation of pregabalin can lead to withdrawal symptoms including:
- Headaches
- Nausea
- Diarrhea
- Insomnia
- Increased sweating
- Anxiety 1
Pregabalin should be tapered gradually over at least one week to minimize withdrawal symptoms 1, 3.
Monitoring Recommendations
- Regular assessment for emergence or worsening of depression, suicidal thoughts or behavior 1
- Weight monitoring due to potential for significant weight gain 1, 4
- Monitoring for peripheral edema, particularly in patients with cardiovascular conditions or taking other medications that may cause fluid retention 1, 2
- Visual examinations if patients report changes in vision 1
Comparison to Similar Medications
Pregabalin has a similar side effect profile to gabapentin, but may have some advantages:
- More predictable absorption
- Linear pharmacokinetics
- Higher bioavailability (approximately 90%) 5
- May be more effective at reducing benzodiazepine use in psychiatric patients compared to gabapentin 3
However, both medications share common side effects including dizziness, somnolence, peripheral edema, and weight gain 6, 2.